CIK 0001662774
- Non-accelerated filer
- Smaller reporting company
IRulya Therapeutics Inc.
Sign in to watch- Ticker
- IRLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 901024039
- Phone
- +1 203-208-8994
- Business address
- 101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
- Former names
- Quince Therapeutics, Inc., Cortexyme, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-13 | PFIZER INC 10% owner | Conversion | +2,360,071 | 2,360,071 | ||
| 2019-05-13 | PFIZER INC 10% owner | Conversion | +215,697 | 2,575,768 | ||
| 2019-05-13 | PFIZER INC 10% owner | Conversion | +624,205 | 3,199,973 | ||
| 2019-05-13 | PFIZER INC 10% owner | Purchase | +50,000 | $17.00 | $850K | 3,249,973 |
| 2019-05-13 | PFIZER INC 10% owner | Conversion · Series A Redeemable Convertible Preferred Stock | −2,360,071 | 0 | ||
| 2019-05-13 | PFIZER INC 10% owner | Conversion · Series B Redeemable Convertible Preferred Stock | −215,697 | 0 | ||
| 2019-05-13 | PFIZER INC 10% owner | Conversion · Series B Redeemable Convertible Preferred Stock | −624,205 | 0 | ||
| 2019-05-13 | Takeda Ventures, Inc. 10% owner | Conversion | +2,679,802 | 2,679,802 | ||
| 2019-05-13 | Takeda Ventures, Inc. 10% owner | Conversion · Series A Redeemable Convertible Preferred Stock | −2,360,071 | 0 | ||
| 2019-05-13 | Takeda Ventures, Inc. 10% owner | Conversion · Series B Redeemable Convertible Preferred Stock | −319,731 | 0 | ||
| 2019-05-13 | LAMOND PIERRE 10% owner | Conversion | +962,510 | 962,510 | ||
| 2019-05-13 | LAMOND PIERRE 10% owner | Conversion | +962,510 | 962,510 | ||
| 2019-05-13 | LAMOND PIERRE 10% owner | Conversion | +961,510 | 961,510 | ||
| 2019-05-13 | LAMOND PIERRE 10% owner | Conversion · Series A Redeemable Convertible Preferred Stock | −500,483 | 0 | ||
| 2019-05-13 | LAMOND PIERRE 10% owner | Conversion · Series A Redeemable Convertible Preferred Stock | −500,482 | 0 | ||
| 2019-05-13 | LAMOND PIERRE 10% owner | Conversion · Series A Redeemable Convertible Preferred Stock | −961,510 | 0 | ||
| 2019-05-13 | LAMOND PIERRE 10% owner | Conversion · Series B Redeemable Convertible Preferred Stock | −462,027 | 0 | ||
| 2019-05-13 | LAMOND PIERRE 10% owner | Conversion · Series B Redeemable Convertible Preferred Stock | −462,028 | 0 | ||
| 2019-05-13 | Lamond David Director | Conversion | +1,623,336 | 1,623,336 | ||
| 2019-05-13 | Lamond David Director | Conversion | +301,829 | 301,829 |
Page 17 of 18 · 350 trades